Results 11 to 20 of about 76 (75)

Respiratory fluoroquinolones in outpatient clinical practice

Медицинский совет, 2015
Advancements in fluoroquinolones (FQ) resulted in the development of the so-called respiratory quinolones which are different from their predecessors in having a stronger clinically significant effect against gram-positive pathogens of relevant human ...
R. S. Kozlov, A. V. Golub
doaj   +1 more source

ГЕНЕТИЧЕСКИЕ МЕХАНИЗМЫ УСТОЙЧИВОСТИ БАКТЕРИЙ К ЦИПРОФЛОКСАЦИНУ (ЛИТЕРАТУРНЫЙ ОБЗОР)

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta
Ципрофлоксацин как представитель группы фторхинолонов широко используется для лечения инфекций, вызванных как грамположительными, так и грамотрицательными бактериями.
М. В. Марцулевич, Т. Н. Соколова   +1 more
doaj   +1 more source

Combined treatment of acute maxillary sinusitis

Медицинский совет, 2015
Chronic rhinosinusitis is a relevant healthcare issue the incidence of which has increased twofold over the past 20 years. According to the literature, the incidence grows with age: in people aged 20 to 29 years, it equals 2.7%, and in people from 50 to ...
A. I. Kryukov, A. B. Turovskiy, G. Y. Tsarapkin, G. N. Izotova, A. S. Tovmasyan, K. M. Fedotkina, D. S. Gorin   +6 more
doaj   +1 more source

The diagnostic and treatment of perforative odontogenic maxillitis

Эндодонтия Today, 2020
It is generally admitted that complications during treatment of chronic odontogenic maxillitis and recurrences of the disease are related to the abnormal architectonics of the nasal cavity and to the pathology of other paranasal sinuses.

doaj  

Moxifloxacin: safety profile

Медицинский совет, 2013
The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.
A. I. Sinopalnikov
doaj   +1 more source

Study of the efficacy and safety of levofloxacin and amoxicillin clavulanate in patients with acute bacterial sinusitis

Медицинский совет, 2014
Currently in Russia, acute sinusitis is diagnosed in 10 million people every year [1, 2]. 15 to 36 % of in-patients at ENT units are people suffering from sinusitis [3].
A. I. Kryukov, N. L. Kunelskaya, A. V. Gurov, G. N. Izotova, G. N. Yushkina   +4 more
doaj   +1 more source

Левофлоксацин (Таваник®) — новый препарат группы фторхинолонов для лечения инфекционных заболеваний с широкими показаниями к применению

Качественная клиническая практика, 2018
Фторхинолоны - одна из важнейших групп для лечения инфекционных заболеваний.

doaj  

Fluoroquinolones in ambulatory surgical practice: whom, when, how?

Амбулаторная хирургия, 2016
The articLe discusses the indications and conditions for the use of fLuoroquinoLones (ciprofloxacin, LevofLoxacin, moxifLoxacin) in surgicaL infections of the skin and soft tissues in ambuLatory patients.
A. V. Golub, V. G. Pleshkov, V. V. Privol'nev   +2 more
doaj  

ЭФЕКТИВНОСТЬ ПРИМЕНЕНИЯ НОВЫХ ПРОТИВОТУБЕРЛЕЗНЫХ ПРЕПАРАТОВ У БОЛЬНЫХ С ШИРОКОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТЬЮ

Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale
Исследование было направлено на оценку эффективности новых противотуберкулезных препаратов у пациентов с широкой лекарственной устойчивостью. Ретроспективный анализ данных 178 пациентов позволил выявить одно из главных достижений - прекращение ...
Гюльбала ГАДЖИЕВ, Эмилия АБДУЛЛАЕВА, Назиля МУРГУЗОВА   +2 more
doaj   +1 more source

Comparative pharmacoeconomic analysis and qualitative evaluation methods of antibiotic prophylaxis during cataract surgery

Качественная клиническая практика, 2018
Purpose. Comparative evaluation of the clinical and cost-effectiveness of perioperative antibiotic prophylaxis systemic fluoroquinolones cataract. Methods.
E. V. Eliseeva, G. A. Fedyashev, P. V. Shellenberg   +2 more
doaj